Vexas clinical trials

Explore recruiting vexas clinical trials.

Recruiting vexas studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vexas trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PAXIS: A randomized, double-blind, placebo-controlled dose-finding phase 2 study (Part 1) followed by an open-label period (Part 2) to assess the efficacy and safety of pacritinib in patients with VEXAS syndrome

Spain, France, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

GFM-VEXAS-MMB: A single-arm phase II with safety run-in multicenter study of momelotinib in patients with VEXAS syndrome with or without associated myelodysplastic syndrome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Patients with VEXAS Syndrome

Denmark, Finland, Sweden, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Vexas trials by city

Vexas in Toronto Vexas in Vancouver Vexas in Montreal Vexas in Calgary Vexas in Edmonton Vexas in Ottawa Vexas in Winnipeg Vexas in Quebec City Vexas in Hamilton Vexas in Kitchener Vexas in London Vexas in Halifax Vexas in New York Vexas in Los Angeles Vexas in Chicago Vexas in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease